EZH2 overexpression significantly suppressed PF-573228-treatment-induced cellular senescence in A549 and H1299 cells (Figure 5), indicating that EZH2 acts as a critical downstream effector of FAK-mediated anti-senescence programming in non-small cell lung cancer cells. The gene discussed is PTK2; the disease is non-small cell lung carcinoma.